Literature DB >> 28360562

Sporadic Creutzfeldt-Jacob Disease: An 8-Year Experience from a Single Center in Turkey.

Özlem Taşkapilioğlu1, Meral Seferoğlu1, Şükran Yurtoğullari1, Bahattin Hakyemez2, Sevda Erer1, Necdet Karli2, Mustafa Bakar1, Ö Faruk Turan1, Mehmet Zarifoğlu1, Şahsine Tolunay2, İbrahim Bora1.   

Abstract

INTRODUCTION: Our aim was to conduct a retrospective review to demonstrate the clinical, radiological, and electrophysiological features of patients with sporadic Creutzfeldt-Jacob disease (sCJD).
METHOD: A total of 10 patients (5 female and 5 male, with a mean age of 45 years from a range of 40 to 67 years) out of 8.259 adult patients hospitalized from January 2000 to December 2008 were diagnosed with sCJD.
RESULTS: Eight of the patients were diagnosed on the basis of clinical, radiological, electroencephalography (EEG), and cerebrospinal fluid (CSF) findings. Two other patients also had a pathological diagnosis. The most common signs and symptoms were behavioral disturbances, movement disorders, cognitive decline, myoclonus, psychosis, focal neurological deficit, and aphasia. Nine of the patients had periodic sharp wave discharges on EEG. Seven patients were positive for the 14.3.3 protein in the CSF. Five patients had pulvinar signs-a bilateral increased signal in the pulvinar thalami-on cranial magnetic resonance imaging. Eight patients were diagnosed with probable sCJD; two were diagnosed with definite sCJD. All of the patients died as a result of the disease within 24 months after the onset of symptoms. DISCUSSION: sCJD should be considered in the diagnosis of patients who present with rapidly progressive dementia. Clinical and radiological data appear to be sufficient for the diagnosis. However, detailed molecular examinations of the subtypes of the disease may be required for early diagnosis of cases given the wide spectra of CJD.

Entities:  

Keywords:  Sporadic Creutzfeldt-Jakob disease; cerebrospinal fluid; magnetic resonance imaging; periodic sharp wave complexes

Year:  2013        PMID: 28360562      PMCID: PMC5363421          DOI: 10.4274/Npa.y5903

Source DB:  PubMed          Journal:  Noro Psikiyatr Ars        ISSN: 1300-0667            Impact factor:   1.339


  19 in total

Review 1.  Diffusion-weighted MR imaging of early-stage Creutzfeldt-Jakob disease: typical and atypical manifestations.

Authors:  Ryutarou Ukisu; Tamio Kushihashi; Eriko Tanaka; Maiko Baba; Nobutaka Usui; Hidefumi Fujisawa; Hiroki Takenaka
Journal:  Radiographics       Date:  2006-10       Impact factor: 5.333

2.  Human transmissible spongiform encephalopathies.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  1998-11-20

3.  The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies.

Authors:  G Hsich; K Kenney; C J Gibbs; K H Lee; M G Harrington
Journal:  N Engl J Med       Date:  1996-09-26       Impact factor: 91.245

Review 4.  Prion diseases.

Authors:  Richard T Johnson
Journal:  Lancet Neurol       Date:  2005-10       Impact factor: 44.182

5.  Creutzfeldt-Jakob disease: comparative analysis of MR imaging sequences.

Authors:  K Kallenberg; W J Schulz-Schaeffer; U Jastrow; S Poser; B Meissner; H J Tschampa; I Zerr; M Knauth
Journal:  AJNR Am J Neuroradiol       Date:  2006-08       Impact factor: 3.825

6.  Relationship between clinical course and Diffusion-weighted MRI findings in sporadic Creutzfeldt-Jakob Disease.

Authors:  Sang-Hun Yi; Key-Chung Park; Sung-Sang Yoon; Eui-Jong Kim; Won-Chul Shin
Journal:  Neurol Sci       Date:  2008-09-20       Impact factor: 3.307

7.  Brain SPECT with 123I-IMP for the early diagnosis of Creutzfeldt-Jakob disease.

Authors:  M Matsuda; K Tabata; T Hattori; J Miki; S Ikeda
Journal:  J Neurol Sci       Date:  2001-01-15       Impact factor: 3.181

8.  A discrepancy between Tc-99m HMPAO SPECT and Tc-99m ECD SPECT in Creutzfeldt-Jacob disease.

Authors:  Ichiro Sunada; Toru Ishida; Shinichi Sakamoto; Naohiro Tsuyuguchi
Journal:  J Clin Neurosci       Date:  2004-08       Impact factor: 1.961

9.  Characteristics of established and proposed sporadic Creutzfeldt-Jakob disease variants.

Authors:  Brian S Appleby; Kristin K Appleby; Barbara J Crain; Chiadi U Onyike; Mitchell T Wallin; Peter V Rabins
Journal:  Arch Neurol       Date:  2009-02

10.  Brain and CSF proteins in Creutzfeldt-Jakob disease.

Authors:  J E Olsson
Journal:  Eur Neurol       Date:  1980       Impact factor: 1.710

View more
  1 in total

1.  An Evaluation of Rapidly Progressive Dementia Culminating in a Diagnosis of Creutzfeldt-Jakob Disease.

Authors:  Parmvir Parmar; Curtis L Cooper; Daniel Kobewka
Journal:  Case Rep Infect Dis       Date:  2018-09-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.